Saturday 17 October 2026 Export CGON’s income statement to Excel — free account

CG Oncology, Inc.

CG Oncology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 million, up 254.7% from fiscal 2024. In the quarter to June 2026, revenue grew 2,125.0%, EPS fell 66.7% and free cash flow fell 67.6%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

59.79 2.07 −3.35%

Follow CGON

Alert me

Market cap: $5.5B
P/E: 0.0×
Fwd P/E: −19.2×
Dividend yield: —
F-score: 2/9
Altman Z: 49.04
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		1,394.08	713.89	1,116.58	1,006.20
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(79.46)	(88.62)	(100.46)	(135.02)
P/B ratio Full definition →		4.49	4.26	5.24	6.09
Price to Tangible BV Full definition →		4.59	4.33	5.29	6.15
EV/Sales Full definition →		1,092.64	551.48	908.84	843.02
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(20.74)	(18.73)	(29.10)	(29.42)
EV/FCF Full definition →		(20.68)	(18.72)	(29.02)	(29.28)
Quick Ratio Full definition →		22.30	24.09	30.60	21.78
Current Ratio Full definition →		22.79	24.63	31.30	22.22
Net Debt/EBITDA Full definition →		12.86	15.76	16.80	11.76
Debt/Assets Full definition →		0.41%	0.38%	0.26%	0.28%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.00	0.01	0.01	0.01
Operating CF/Net income Full definition →		0.89	0.88	0.95	0.59
Capex/Depreciation Full definition →		0.06	0.00	(0.12)	0.57
Research and Development Expense of Revenue Full definition →		1,673.71%	1,290.22%	4,037.86%	4,724.03%
Selling, General and Administrative Expense of Revenue Full definition →		1,400.60%	774.89%	1,918.74%	2,504.41%
Intangible Assets out of Total Assets Full definition →		0.02	0.01	0.01	0.01
Share Based Compensation of Revenue Full definition →		440.04%	309.52%	597.78%	1,238.89%
Graham Net Nets Full definition →		0.21	0.22	0.19	0.16
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(5.06%)	(4.99%)	(3.44%)	(3.79%)
Free Cash Flow Yield Full definition →		(3.79%)	(4.13%)	(2.80%)	(2.86%)
Revenue per Share Full definition →		0.02	0.03	0.01	0.01
Operating CF per Share Full definition →		(0.51)	(0.47)	(0.67)	(0.53)
Capex per Share Full definition →		0.00	0.00	0.00	(0.01)
Free Cash Flow per Share Full definition →		(0.51)	(0.47)	(0.68)	(0.53)
Cash per Share Full definition →		8.87	9.60	12.73	11.66
Shareholders Equity per Share Full definition →		8.96	9.74	12.92	11.67
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		8.96	9.74	12.92	11.67
Free Cash Flow Full definition →		(38.99)	(36.22)	(57.25)	(46.88)
Working Capital Full definition →		665.26	728.64	1,066.93	1,002.41
Capital Expenditures Full definition →		(0.10)	(0.01)	(0.30)	(0.47)
Net Current Asset Value Full definition →		653.52	720.49	1,058.66	993.11
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.06	0.00	0.28	0.40
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		0.33	0.73	0.81	0.49
Average Payables Full definition →		6.63	6.12	7.48	9.93
Average Assets Full definition →		641.19	773.19	931.72	893.55
Average Common Equity Full definition →		612.21	742.99	898.27	849.74

Show all line items

Columns are period end dates

Stockrow Weekly